Treatment with PCSK9 inhibitors in patients with chronic kidney disease at very high cardiovascular risk

• José Manuel Amaro,
• Florentino Villanego,
• Javier Naranjo,
• Cristhian Orellana,
• Luis Alberto Vigara,
• Carlos Eduardo Narváez,
• Julia Torrado,
• Juan Manuel Cazorla,
• Claudia Rodríguez,
• Auxiliadora Mazuecos

Affiliations

José Manuel Amaro

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Florentino Villanego

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Javier Naranjo

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Cristhian Orellana

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Luis Alberto Vigara

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Carlos Eduardo Narváez

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Julia Torrado

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Juan Manuel Cazorla

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Claudia Rodríguez

Hospital Pharmacy Department, Hospital Universitario Puerta del Mar, Cádiz, Spain

Auxiliadora Mazuecos

Nephrology Department, Hospital Universitario Puerta del Mar, Cádiz, Spain; Corresponding author.